Peptides After 40: What Changes and What Actually Helps
Somewhere in your forties, the arithmetic changes. The same training produces less. Recovery takes an extra day. Weight settles differently. Sleep gets shallower without getting shorter. None of that is imagination — it's measurable physiology, and it's worth understanding properly before you spend money on solutions. This is what actually declines, what the evidence supports doing about it, and where peptides genuinely fit.
Before anything else: get your bloods done
This is the most useful advice in the article, so it goes first.
A great deal of what people file under "getting older" is a treatable condition wearing a disguise. Fatigue, low mood, poor recovery, weight gain, brain fog and loss of drive are the presenting symptoms of hypothyroidism, low testosterone, iron deficiency, vitamin D deficiency, sleep apnea, early insulin resistance and depression — all common in this age group, all diagnosable with a blood test and a conversation, and all treatable.
Spending six months and a few hundred dollars on compounds while an untreated thyroid problem or undiagnosed sleep apnea sits underneath is a genuinely bad trade. Sleep apnea in particular is worth naming: it's strongly linked to the same axes discussed below, it's massively underdiagnosed in men over 40, and treating it changes more than any supplement will.
Get a baseline panel. Then read the rest of this.
What actually changes after 40
Four systems shift, and they interact.
Growth hormone — the "somatopause"
This is the most dramatic decline of the lot. Growth hormone production falls by roughly 14% per decade after age 30, and some estimates put it at up to 50% every seven years in adult men. To put that in perspective: an older man may produce around 50 micrograms a day, against 1.0–1.5 milligrams a day in a pubertal boy — a twenty-fold difference.
IGF-1, the downstream mediator, falls with it. In one analysis, 85% of healthy men aged 59–98 had IGF-1 levels below the 2.5th percentile for young men, and around 35% of men over 60 met criteria for growth hormone deficiency.
Testosterone
In men, testosterone declines at roughly 1% per year from around age 30–40. In women, circulating testosterone falls more steeply between ages 20 and 45. In men particularly, this tracks with declining muscle mass and strength.
Muscle — sarcopenia and anabolic resistance
Two separate things happen here, and the second is more important than most people realise.
The first is structural: muscle fibre number drops by 30–40% over the lifespan, and type II fibres — the fast, powerful ones — become 10–40% smaller. There's also a shift from fast to slow fibre types.
The second is anabolic resistance. Older muscle responds less efficiently to the same stimulus. The same protein meal and the same training session produce a blunted muscle protein synthesis response compared with a younger person. You aren't imagining that identical effort yields less — the receiving end has genuinely become less sensitive.
Bone and connective tissue
Bone IGF-1 content and its binding protein decline by around 60% between ages 20 and 60. Collagen turnover slows generally, which is why tendon injuries in your forties resolve on a different timescale than they did at twenty-five.
The numbers
- ~14% per decade — growth hormone production decline after 30
- ~1% per year — testosterone decline in men from 30–40
- 30–40% — lifetime reduction in muscle fibre number
- ~60% — decline in bone IGF-1 content between 20 and 60
- 200 → 80 ng/mL — plasma GHK-Cu from young adulthood to age 60
What the evidence says helps most
Here's the part that isn't going to sell you anything, and it's the part that matters most.
Resistance training
Nothing else comes close. Reviews of interventions for age-related muscle loss consistently land in the same place: resistance training is the most effective intervention for building and maintaining muscle mass and strength in older adults. Not "a good addition" — the most effective thing available, by a wide margin.
It also directly addresses anabolic resistance. The blunted response can be substantially overcome by structured resistance training, which is one of the more encouraging findings in the whole field.
Protein — more than you think
Because of anabolic resistance, the standard RDA of 0.8 g/kg is inadequate for this age group. Consensus recommendations for healthy older adults sit at 1.0–1.2 g/kg per day, rising to 1.2–2.0 g/kg with illness or higher demands.
If you're training, aim higher. A meta-analysis of 49 randomised trials covering 1,863 participants found that around 1.6 g/kg per day maximises resistance-training-induced gains in muscle and strength.
Distribution matters as much as total. Roughly 25–30 g of high-quality protein per meal is the threshold usually cited for triggering muscle protein synthesis in older adults — one large protein meal a day doesn't achieve what three moderate ones do.
Sleep
Growth hormone release is concentrated in deep sleep, and deep sleep declines with age. This creates a loop: less slow-wave sleep, less GH, worse recovery, worse sleep. Fixing sleep is one of the few interventions that acts on several of these systems simultaneously — and it's free.
The growth hormone question, answered honestly
Given that GH falls further than anything else, replacing it looks like the obvious move. The evidence is more interesting than that.
Controlled studies of GH supplementation in older men show an increase in lean mass of roughly 2 kg, with a similar reduction in fat mass. That sounds good — until you read the next finding.
There is little evidence that GH treatment improves muscle strength, physical performance or quality of life. Walking speed, stair-climbing ability, actual function: unchanged. You gain lean mass without gaining the things lean mass is supposed to give you.
The most rigorous assessment, a systematic review of 18 randomised trials in healthy older adults published in the Annals of Internal Medicine, concluded that growth hormone produced small body-composition changes alongside increased adverse events, and could not be recommended as an anti-ageing therapy.
There's a further complication worth sitting with: animal models of congenital growth hormone deficiency show markedly increased lifespan, and the somatopause has been described in the literature as possibly adaptive — a reduction in growth signalling that lowers cancer risk. The relationship between GH and ageing does not run in the simple direction the marketing implies.
We've covered this in more depth in our guide to somatropin.
Where peptides actually fit
With that context, the peptide picture becomes clearer — and more interesting than "replace what's declining."
Tesamorelin — the strongest case
Tesamorelin has the best evidence of anything in this category for this age group, and it's specifically noted in the ageing literature. Unlike direct GH replacement, it restores normal GH pulsatility and amplitude — the natural rhythm — rather than flooding the system.
What the reviews credit it with: selective reduction of visceral fat, reduced carotid intima-media thickness, lower triglycerides, and improved cognitive function in older adults. The trial numbers are solid — visceral fat down 10.9% versus 0.6% on placebo at 26 weeks in a 412-patient trial, with a pooled analysis of 806 patients showing around 15.4% at 26 weeks sustained through 52.
Visceral fat matters more than the scale here. It's the metabolically active fat around the organs, and it's the deposit most associated with cardiovascular and metabolic risk.
Other GH secretagogues
Sermorelin, ipamorelin and CJC-1295 work through the same receptor family and preserve the same pulsatile pattern. The honest caveat is that controlled body-composition data specific to these compounds is limited — the strong numbers above belong to tesamorelin. Shared mechanism supports plausibility; it isn't the same as evidence.
GHK-Cu
Plasma GHK-Cu falls from around 200 ng/mL in young adults to roughly 80 ng/mL by 60 — one of the clearest age-related declines of any signalling molecule. It has genuine research behind collagen synthesis and skin quality, with human facial trials reporting around 22% improved firmness and 16% reduction in fine lines, plateauing around week 10.
Metabolic and mitochondrial compounds
NAD+, MOTS-c and SS-31 target mitochondrial function, which does decline with age and contributes to the accumulation of reactive oxygen species implicated in sarcopenia. The mechanism is real. Human outcome data in healthy ageing adults is thin, and it's worth being clear that mechanistic plausibility is where this currently sits.
Ranked by evidence, not by promise
| Intervention | Evidence | What it does |
|---|---|---|
| Resistance training | Strong | Most effective intervention for muscle mass and strength; overcomes anabolic resistance |
| Protein 1.2–1.6 g/kg | Strong | Supports muscle protein synthesis; distribution across meals matters |
| Treating undiagnosed conditions | Strong | Thyroid, testosterone, sleep apnea, vitamin D — often the actual cause |
| Sleep quality | Strong | GH release, recovery, appetite regulation, cognition |
| Tesamorelin | Good | Visceral fat, lipids, cognition in older adults |
| GHK-Cu (skin) | Moderate | Collagen synthesis, firmness, fine lines |
| Other GH secretagogues | Limited | Shared mechanism with tesamorelin; own data sparse |
| Direct GH replacement | Negative for this use | ~2 kg lean mass, no strength or function benefit, more adverse events |
| Mitochondrial compounds | Mechanistic only | Plausible pathway, little human outcome data |
The recovery problem
For anyone still training seriously, recovery is usually what changes first and bothers most.
Several things converge. Slow-wave sleep — where most GH release happens — declines. Collagen turnover in tendon and ligament slows. Anabolic resistance means each session produces a smaller adaptive signal. Chronic low-grade inflammation rises. The result is the familiar pattern: the session felt the same, the soreness lasts two days longer, and niggles that used to clear in a week now linger for a month.
What actually helps here is unglamorous. Sleep is the highest-leverage intervention, followed by protein timing, followed by managing total training load rather than pushing through. Repair peptides like BPC-157 and TB-4 get discussed constantly in this context, and it's worth being straight: their research is preclinical, with no completed controlled human efficacy trials. The interest is understandable; the evidence isn't there yet.
The uncomfortable truth about training in your forties is that the biggest gains come from subtraction — fewer junk sessions, more sleep, better load management — rather than addition.
A sensible order of operations
- Get bloodwork. Thyroid, testosterone, ferritin, vitamin D, HbA1c, lipids. Rule out the treatable things first.
- Fix sleep. Including getting assessed for sleep apnea if you snore, wake unrefreshed, or your partner has mentioned it.
- Train resistance, consistently. Two to three sessions weekly, progressive, compound movements. This is the intervention with the strongest evidence and it isn't close.
- Get protein right. 1.2–1.6 g/kg, spread across meals at 25–30 g each.
- Then consider whether a compound adds something on top of a foundation that's actually in place.
Steps 1–4 are where the evidence is. Step 5 is where the marketing is. That ordering isn't a criticism of step 5 — it's just the honest sequence, and skipping to it is the most common and most expensive mistake in this space.
Explore anti-aging research compounds
Research-grade compounds studied for growth hormone signalling, collagen synthesis and mitochondrial function — every batch third-party tested, results published openly.
View anti-aging peptidesFrequently asked questions
What actually declines after 40?
Growth hormone falls by roughly 14% per decade after 30. Testosterone declines about 1% per year in men from 30–40. Muscle loses fibres and the remaining fast-twitch fibres shrink. And muscle develops anabolic resistance — responding less efficiently to the same protein and training stimulus. Bone IGF-1 content drops around 60% between 20 and 60.
Should I take growth hormone?
The evidence doesn't support it for healthy ageing. Controlled studies show roughly 2 kg lean mass gain with similar fat loss, but little evidence of improved strength, physical performance or quality of life — and a systematic review of 18 trials found small body-composition changes alongside increased adverse events, concluding it can't be recommended as an anti-ageing therapy.
What's the single most effective thing?
Resistance training. Reviews consistently find it the most effective intervention for maintaining muscle mass and strength in older adults, and it directly counteracts anabolic resistance. Nothing in the supplement or peptide category comes close to that level of evidence.
How much protein do I need after 40?
More than the standard RDA of 0.8 g/kg, because of anabolic resistance. Consensus for healthy older adults is 1.0–1.2 g/kg daily, and around 1.6 g/kg maximises resistance-training gains according to a meta-analysis of 49 trials. Spread it across meals at roughly 25–30 g each rather than concentrating it in one sitting.
Which peptide has the best evidence for this age group?
Tesamorelin. It restores normal GH pulsatility rather than replacing the hormone, and the ageing literature credits it with selectively reducing visceral fat, lowering triglycerides and carotid intima-media thickness, and improving cognitive function in older adults. Trial data shows around 10.9–15.4% visceral fat reduction at 26 weeks.
Why does recovery take so much longer now?
Several things at once: less slow-wave sleep (where most GH is released), slower collagen turnover in tendon and ligament, anabolic resistance blunting the adaptive signal, and higher baseline inflammation. Sleep is the highest-leverage thing to address, followed by protein and managing total training load.
Is it too late to build muscle?
No. Anabolic resistance means the response is blunted, not absent, and structured resistance training substantially overcomes it. Older adults consistently gain muscle and strength with progressive training in trials. It takes more deliberate effort than at twenty-five — but the adaptation is still there.
The bottom line
The decline after 40 is real and measurable — growth hormone, testosterone, muscle fibres, connective tissue and the sensitivity of the whole system to anabolic signals. You aren't imagining any of it.
What's less intuitive is which interventions actually address it. Direct growth hormone replacement looks like the obvious fix and performs poorly — lean mass without strength or function, at the cost of more adverse events. Resistance training and adequate protein look mundane and consistently outperform everything else studied.
Peptides have a legitimate place in that picture, with tesamorelin holding the strongest position and the rest ranging from moderate to mechanistic. But they work on top of a foundation, not instead of one — and the compounds that get discussed most enthusiastically in this space are frequently the ones with the least human data behind them.
Get your bloods done. Lift something heavy three times a week. Eat the protein. Sleep properly. Then decide what, if anything, to add.
For compound-specific detail, our Info Center covers each individually.
This article is provided for educational and informational purposes only. It is not medical advice, and it is not intended to diagnose, treat, cure or prevent any condition. Symptoms commonly attributed to ageing can indicate underlying medical conditions that are diagnosable and treatable — anyone experiencing persistent fatigue, weight change, low mood, or loss of strength should be assessed by a qualified healthcare professional. Products offered by Peptides Costa Rica are intended strictly for laboratory research use only. They are not approved or licensed by the FDA for the prevention, diagnosis, treatment or cure of any disease. Not for human or veterinary use.
